药物治疗服务采购:对模型,目标和结果的系统审查
Taina Schneider1, Kristiina Kuussaari2, Petri Virtanen3
1University of Vaasa, Finnish Institute for Health and Welfare, Helsinki, Finland.
Nordisk alkohol- & narkotikatidskrift : NAT
|November 16, 2023
概括
经合组织国家对药物治疗服务的公共采购显示出多种模式. 竞争和激励不会提高服务效率,质量或结果,突出了利益相关者共同创造价值的研究差距.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 公共卫生政策 公共卫生政策
- 卫生经济学 卫生经济学
背景情况:
- 医疗保健服务的公共采购是复杂的.
- 药物治疗服务需要特定的采购和交付方法.
- 了解采购模式对于改善服务至关重要.
研究的目的:
- 探索经合组织国家的药物治疗服务公共采购的目标和结果.
- 识别和分析这些服务的不同采购模式.
- 调查如何采购和提供复杂的药物治疗服务.
主要方法:
- 从1990年到2020年进行的系统文献综述.
- 识别和分类四种采购模式:传统的,以价值为基础的,以结果为基础的和创新的.
- 对专注于获取药物治疗服务的经验研究进行分析.
主要成果:
- 尽管采购形式多样化,但确定了12项采购经验研究.
- 这四种已识别的模型在设计,性能规格以及竞争和协作的角色上有所不同.
- 采购模式在共同创造价值的方法上有所不同.
结论:
- 竞争和激励措施并不能提高复杂的药物治疗服务的效率,质量或结果.
- 关于与服务用户和利益相关者共同创造价值的研究缺口存在.
- 专注于支付机制忽视了在服务提供中共同创造价值的关键方面.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
162
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
162
Pharmacokinetic Models: Overview
717
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
717
Drug Administration and Therapy Phases: Overview
478
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
478
Pharmacokinetic Models: Comparison and Selection Criterion
78
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
78
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Structure-Activity Relationships and Drug Design
733
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
733


